Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy

INDEED Study

Seong Wook Park, Seung Whan Lee, Bon Kwon Koo, Duk Woo Park, Se Whan Lee, Young Hak Kim, Cheol Whan Lee, Myeongki Hong, Jae Joong Kim, Ken Mori, Alexandra J. Lansky, Gary S. Mintz, Myoung Mook Lee, Seung Jung Park

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: We compared sirolimus-eluting stent (SES) implantation and intracoronary brachytherapy (ICBT) for diffuse bare metal in-stent restenosis (ISR) to identify more effective treatment modality. Methods: Patients (n = 129) with diffuse ISR (lesion length ≥ 10 mm) were randomly assigned to either SES implantation (n = 65, group I) or beta-radiation with 188Re-MAG3-filled balloon (n = 64, group II). The radiation dose was 20 Gy at a depth of 1.0 mm into the vessel wall. The primary end point was late loss in analysis segment at 6 months. The secondary end points were 6-month angiographic restenosis and 1-year major adverse cardiac events (MACE) including myocardial infarction (MI), cardiac death, and target lesion revascularization (TLR). Results: Baseline characteristics were similar between two groups. The lesion length was 27.52 ± 13.98 mm in group I and 27.75 ± 14.25 mm in group II (p = 0.927). Late loss in analysis segment at 6 months was smaller in group I than in group II (0.15 ± 0.62 vs. 0.55 ± 0.69 mm, p = 0.003). Angiographic restenosis for analysis segment at 6 months was 8.0% (4/50) in group I and 30.2% (16/53) in group II (p = 0.006). One MI and two deaths (all from group I) occurred during follow-up. TLR (4.6% vs. 18.8%, p = 0.014) and MACEs (7.7% vs. 18.8%, p = 0.073) were lower in group I than group II at 1 year. Conclusion: Compared to ICBT, SES implantation for diffuse bare metal ISR showed less late loss, lower restenosis, and a trend toward lower 1-year MACEs. SES implantation appears to be superior to ICBT for treating diffuse ISR.

Original languageEnglish
Pages (from-to)70-77
Number of pages8
JournalInternational Journal of Cardiology
Volume131
Issue number1
DOIs
Publication statusPublished - 2008 Dec 17

Fingerprint

Beta Particles
Drug-Eluting Stents
Stents
Radiotherapy
Sirolimus
Brachytherapy
Therapeutics
Metals
Myocardial Infarction
Radiation

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Park, Seong Wook ; Lee, Seung Whan ; Koo, Bon Kwon ; Park, Duk Woo ; Lee, Se Whan ; Kim, Young Hak ; Lee, Cheol Whan ; Hong, Myeongki ; Kim, Jae Joong ; Mori, Ken ; Lansky, Alexandra J. ; Mintz, Gary S. ; Lee, Myoung Mook ; Park, Seung Jung. / Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy : INDEED Study. In: International Journal of Cardiology. 2008 ; Vol. 131, No. 1. pp. 70-77.
@article{a0f2e0a55639453d9a2762d027d9ba16,
title = "Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy: INDEED Study",
abstract = "Background: We compared sirolimus-eluting stent (SES) implantation and intracoronary brachytherapy (ICBT) for diffuse bare metal in-stent restenosis (ISR) to identify more effective treatment modality. Methods: Patients (n = 129) with diffuse ISR (lesion length ≥ 10 mm) were randomly assigned to either SES implantation (n = 65, group I) or beta-radiation with 188Re-MAG3-filled balloon (n = 64, group II). The radiation dose was 20 Gy at a depth of 1.0 mm into the vessel wall. The primary end point was late loss in analysis segment at 6 months. The secondary end points were 6-month angiographic restenosis and 1-year major adverse cardiac events (MACE) including myocardial infarction (MI), cardiac death, and target lesion revascularization (TLR). Results: Baseline characteristics were similar between two groups. The lesion length was 27.52 ± 13.98 mm in group I and 27.75 ± 14.25 mm in group II (p = 0.927). Late loss in analysis segment at 6 months was smaller in group I than in group II (0.15 ± 0.62 vs. 0.55 ± 0.69 mm, p = 0.003). Angiographic restenosis for analysis segment at 6 months was 8.0{\%} (4/50) in group I and 30.2{\%} (16/53) in group II (p = 0.006). One MI and two deaths (all from group I) occurred during follow-up. TLR (4.6{\%} vs. 18.8{\%}, p = 0.014) and MACEs (7.7{\%} vs. 18.8{\%}, p = 0.073) were lower in group I than group II at 1 year. Conclusion: Compared to ICBT, SES implantation for diffuse bare metal ISR showed less late loss, lower restenosis, and a trend toward lower 1-year MACEs. SES implantation appears to be superior to ICBT for treating diffuse ISR.",
author = "Park, {Seong Wook} and Lee, {Seung Whan} and Koo, {Bon Kwon} and Park, {Duk Woo} and Lee, {Se Whan} and Kim, {Young Hak} and Lee, {Cheol Whan} and Myeongki Hong and Kim, {Jae Joong} and Ken Mori and Lansky, {Alexandra J.} and Mintz, {Gary S.} and Lee, {Myoung Mook} and Park, {Seung Jung}",
year = "2008",
month = "12",
day = "17",
doi = "10.1016/j.ijcard.2007.09.003",
language = "English",
volume = "131",
pages = "70--77",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Park, SW, Lee, SW, Koo, BK, Park, DW, Lee, SW, Kim, YH, Lee, CW, Hong, M, Kim, JJ, Mori, K, Lansky, AJ, Mintz, GS, Lee, MM & Park, SJ 2008, 'Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy: INDEED Study', International Journal of Cardiology, vol. 131, no. 1, pp. 70-77. https://doi.org/10.1016/j.ijcard.2007.09.003

Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy : INDEED Study. / Park, Seong Wook; Lee, Seung Whan; Koo, Bon Kwon; Park, Duk Woo; Lee, Se Whan; Kim, Young Hak; Lee, Cheol Whan; Hong, Myeongki; Kim, Jae Joong; Mori, Ken; Lansky, Alexandra J.; Mintz, Gary S.; Lee, Myoung Mook; Park, Seung Jung.

In: International Journal of Cardiology, Vol. 131, No. 1, 17.12.2008, p. 70-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy

T2 - INDEED Study

AU - Park, Seong Wook

AU - Lee, Seung Whan

AU - Koo, Bon Kwon

AU - Park, Duk Woo

AU - Lee, Se Whan

AU - Kim, Young Hak

AU - Lee, Cheol Whan

AU - Hong, Myeongki

AU - Kim, Jae Joong

AU - Mori, Ken

AU - Lansky, Alexandra J.

AU - Mintz, Gary S.

AU - Lee, Myoung Mook

AU - Park, Seung Jung

PY - 2008/12/17

Y1 - 2008/12/17

N2 - Background: We compared sirolimus-eluting stent (SES) implantation and intracoronary brachytherapy (ICBT) for diffuse bare metal in-stent restenosis (ISR) to identify more effective treatment modality. Methods: Patients (n = 129) with diffuse ISR (lesion length ≥ 10 mm) were randomly assigned to either SES implantation (n = 65, group I) or beta-radiation with 188Re-MAG3-filled balloon (n = 64, group II). The radiation dose was 20 Gy at a depth of 1.0 mm into the vessel wall. The primary end point was late loss in analysis segment at 6 months. The secondary end points were 6-month angiographic restenosis and 1-year major adverse cardiac events (MACE) including myocardial infarction (MI), cardiac death, and target lesion revascularization (TLR). Results: Baseline characteristics were similar between two groups. The lesion length was 27.52 ± 13.98 mm in group I and 27.75 ± 14.25 mm in group II (p = 0.927). Late loss in analysis segment at 6 months was smaller in group I than in group II (0.15 ± 0.62 vs. 0.55 ± 0.69 mm, p = 0.003). Angiographic restenosis for analysis segment at 6 months was 8.0% (4/50) in group I and 30.2% (16/53) in group II (p = 0.006). One MI and two deaths (all from group I) occurred during follow-up. TLR (4.6% vs. 18.8%, p = 0.014) and MACEs (7.7% vs. 18.8%, p = 0.073) were lower in group I than group II at 1 year. Conclusion: Compared to ICBT, SES implantation for diffuse bare metal ISR showed less late loss, lower restenosis, and a trend toward lower 1-year MACEs. SES implantation appears to be superior to ICBT for treating diffuse ISR.

AB - Background: We compared sirolimus-eluting stent (SES) implantation and intracoronary brachytherapy (ICBT) for diffuse bare metal in-stent restenosis (ISR) to identify more effective treatment modality. Methods: Patients (n = 129) with diffuse ISR (lesion length ≥ 10 mm) were randomly assigned to either SES implantation (n = 65, group I) or beta-radiation with 188Re-MAG3-filled balloon (n = 64, group II). The radiation dose was 20 Gy at a depth of 1.0 mm into the vessel wall. The primary end point was late loss in analysis segment at 6 months. The secondary end points were 6-month angiographic restenosis and 1-year major adverse cardiac events (MACE) including myocardial infarction (MI), cardiac death, and target lesion revascularization (TLR). Results: Baseline characteristics were similar between two groups. The lesion length was 27.52 ± 13.98 mm in group I and 27.75 ± 14.25 mm in group II (p = 0.927). Late loss in analysis segment at 6 months was smaller in group I than in group II (0.15 ± 0.62 vs. 0.55 ± 0.69 mm, p = 0.003). Angiographic restenosis for analysis segment at 6 months was 8.0% (4/50) in group I and 30.2% (16/53) in group II (p = 0.006). One MI and two deaths (all from group I) occurred during follow-up. TLR (4.6% vs. 18.8%, p = 0.014) and MACEs (7.7% vs. 18.8%, p = 0.073) were lower in group I than group II at 1 year. Conclusion: Compared to ICBT, SES implantation for diffuse bare metal ISR showed less late loss, lower restenosis, and a trend toward lower 1-year MACEs. SES implantation appears to be superior to ICBT for treating diffuse ISR.

UR - http://www.scopus.com/inward/record.url?scp=56349164629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349164629&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2007.09.003

DO - 10.1016/j.ijcard.2007.09.003

M3 - Article

VL - 131

SP - 70

EP - 77

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -